EC Number |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
---|
3.1.2.6 | -999 |
- |
- |
650187, 652537 |
3.1.2.6 | -999 |
- |
activity is determined spectrophotometrically at 240 nm, the hepatic glyoxalase II activity of the 3'-methyl-4-dimethylaminoazobenzene group (10 weeks fed) is almost the same as that of the control group |
690300 |
3.1.2.6 | -999 |
- |
activity of wild-type and mutants in crude extracts |
652207 |
3.1.2.6 | -999 |
- |
after the onset of interfering RNAi, GLX II activity in extracts of bloodstream cells is decreased to about 20% when compared to the respective non-induced cells |
694072 |
3.1.2.6 | -999 |
- |
determined spectrophotometrically at 240 nm, glyoxalase II activities of 2-methyl-4-dimethylaminoazobenzene-fed rats (10 weeks fed) are 1.3 times higher than that of the control rats |
690300 |
3.1.2.6 | -999 |
- |
determined spectrophotometrically at 240 nm, glyoxalase II activities of 4'-methyl-4-dimethylaminoazobenzene-fed rats (10 weeks fed) are 1.4 times higher than that of the control rats |
690300 |
3.1.2.6 | -999 |
- |
overexpression of GLX II has no apparent effect on Trypanosoma brucei |
694072 |
3.1.2.6 | 0.04 |
- |
clone B2 (pHD678/GLXII) plus tetracycline, GLX II activity in bloodstream Trypanosoma brucei subject to RNA interference |
694072 |
3.1.2.6 | 0.05 |
- |
clone B4 (p2T7/GLXII) plus tetracycline, GLX II activity in bloodstream Trypanosoma brucei subject to RNA interference |
694072 |
3.1.2.6 | 0.21 |
- |
wild-type minus tetracycine, GLX II activity in bloodstream Trypanosoma brucei subject to RNA interference |
694072 |